Serotonin Synthesis and Uptake in Symptomatic Patients With Crohn’s Disease in Remission  Itta M. Minderhoud, Bas Oldenburg, Marguerite E.I. Schipper, José J.M. ter Linde, Melvin Samsom  Clinical Gastroenterology and Hepatology  Volume 5, Issue 6, Pages 714-720 (June 2007) DOI: 10.1016/j.cgh.2007.02.013 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 TpH-1 mRNA expression in the colon. CD patients in remission with IBS-like (CD + IBS) symptoms show a higher TpH-1 level compared with controls (HC) (*P ≤ .005) and compared with CD patients in remission without IBS-like symptoms (CD-IBS; †P ≤ .01). Clinical Gastroenterology and Hepatology 2007 5, 714-720DOI: (10.1016/j.cgh.2007.02.013) Copyright © 2007 AGA Institute Terms and Conditions

Figure 2 The number of (A) enteroendocrine cells and (B) EC cells per colonic gland in healthy controls (HC), CD patients in remission with IBS-like symptoms (CD + IBS), and CD patients in remission without IBS-like symptoms (CD-IBS). Values represent medians and ranges. Clinical Gastroenterology and Hepatology 2007 5, 714-720DOI: (10.1016/j.cgh.2007.02.013) Copyright © 2007 AGA Institute Terms and Conditions